Status:
SUSPENDED
Pharmacogenetic Testing and Chronic Pain
Lead Sponsor:
Canadian Forces Health Services Centre Ottawa
Conditions:
Chronic Pain
Eligibility:
All Genders
18-60 years
Brief Summary
Understanding the impact of genetics could aid rational, precision drug choices. In the current study, investigators will focus on whether genetic analysis of drug processing using the Inagene platfor...
Detailed Description
Understanding the impact of genetics could aid rational, precision drug choices. In the current study, investigators will focus on whether genetic analysis of drug processing using the Inagene platfor...
Eligibility Criteria
Inclusion
- male and female between 18 and 60 years old
- seen within the CFO-P
- diagnosed by a physician with one or more chronic pain condition.
Exclusion
- adults who are unable to give their own consent
- contraindications to a buccal swab
- uncontrolled mental health issues determined by clinical judgement without mental health treatment and/or presence of active suicidal ideation
Key Trial Info
Start Date :
September 21 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT05259865
Start Date
September 21 2025
End Date
December 31 2027
Last Update
February 13 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Canadian Forces Health Services Centre
Ottawa, Ontario, Canada, K1J6L4